CPRiL

C15H14N2O

CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C

InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-

• Semaxanib
• 204005-46-9
• Semaxinib
SU5416
SU 5416
194413-58-6
Semoxind
SU-5416
Semaxanib (SU5416)
(Z)-3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one
TSU 16
Z-Semaxanib
(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one
NSC-696819
(Z)-SU 5416
1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon
71IA9S35AJ
CHEMBL276711
3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one
(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one
2H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-
3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole
NCGC00094381-03
3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone
SU005416
DTXCID9021132
Semaxnib
Sugen 5416
3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one